Makers Labs, a company in the Pharmaceuticals industry, reported revenue of ₹48 crore and net profit of ₹8.53 crore for the September 2026 quarter.
Makers Labs. (NSE: MAKERSL-BE) closed at ₹255.24 on 20 Nov 2026. Its market capitalisation is ₹151 crore and it trades at 20.1 times earnings.
Incorporated in 1984, Makers Laboratories Ltd manufactures and markets around 200 pharma formulations.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.